Molecular Pharmaceutics
[ASAP] Lipoic Acid-Based Poly(disulfide)s as Versatile Biomolecule Delivery Vectors and the Application in Tumor Immunotherapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00231
Molecular Pharmaceutics
[ASAP] Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00069
Molecular Pharmaceutics
[ASAP] Development of Edaravone Ionic Liquids and Their Application for the Treatment of Cerebral Ischemia/Reperfusion Injury
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00103
Molecular Pharmaceutics
[ASAP] Optimized Carbohydrate-Based Nanogel Formulation to Sensitize Hypoxic Tumors
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00101
Molecular Pharmaceutics
[ASAP] Chemometrics in Protein Formulation: Stability Governed by Repulsion and Protein Unfolding
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00013
Molecular Pharmaceutics
[ASAP] Reconstituted Lipid Nanoparticles from Cells/Tissues for Drug Delivery in Cancer
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01033
Molecular Pharmaceutics
[ASAP] Regional Transcriptomics and Proteomics of Pharmacokinetics-Related Genes in Human Intestine
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01002
Molecular Pharmaceutics
[ASAP] Characterization of Bile Acid Sulfate Conjugates as Substrates of Human Organic Anion Transporting Polypeptides
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00040
Molecular Pharmaceutics
[ASAP] Kinetic Stability and Glass-Forming Ability of Thermally Labile Quinolone Antibiotics
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00211
Molecular Pharmaceutics
[ASAP] Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01013